NOVONIX Balance Sheet Health

Financial Health criteria checks 3/6

NOVONIX has a total shareholder equity of $158.1M and total debt of $64.6M, which brings its debt-to-equity ratio to 40.9%. Its total assets and total liabilities are $240.8M and $82.8M respectively.

Key information

40.9%

Debt to equity ratio

US$64.59m

Debt

Interest coverage ration/a
CashUS$47.13m
EquityUS$158.07m
Total liabilitiesUS$82.77m
Total assetsUS$240.84m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: NVNX.F's short term assets ($57.9M) exceed its short term liabilities ($9.4M).

Long Term Liabilities: NVNX.F's short term assets ($57.9M) do not cover its long term liabilities ($73.4M).


Debt to Equity History and Analysis

Debt Level: NVNX.F's net debt to equity ratio (11%) is considered satisfactory.

Reducing Debt: NVNX.F's debt to equity ratio has reduced from 108.8% to 40.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NVNX.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: NVNX.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 40.4% each year


Discover healthy companies